Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase <scp>III</scp> randomized, double‐blind, placebo‐controlled trial

Summary Purpose Brivaracetam ( BRV ) is a novel high‐affinity synaptic vesicle protein 2A ligand currently being investigated for the treatment of epilepsy. The purpose of this phase III study was to evaluate the efficacy and safety/tolerability of adjunctive BRV in adults with uncontrolled partial‐...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Victor Biton, Samuel F. Berkovic, Bassel Abou‐Khalil, Michael R. Sperling, Martin Johnson, Sarah Lu
Formaat: Artigo
Taal:Engels
Gepubliceerd in: 2013
Online toegang:https://doi.org/10.1111/epi.12433
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/epi.12433
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!